Opportunistic Infections Citation List:
July 8 - July 21, 2011
ANTIFUNGAL COMPOUNDS ( includes Cryptococcus, Aspergillus, Candida, & Histoplasma)
1. Novel hybrids of Fluconazole and Furanones: Design, Synthesis and Antifungal Activity. Borate, H.B., S.P. Sawargave, S.P. Chavan, M.A. Chandavarkar, R. Iyer, A. Tawte, D. Rao, J.V. Deore, A.S. Kudale, P.S. Mahajan, and G.S. Kangire. Bioorganic & Medicinal Chemistry Letters, 2011. [Epub ahead of print]; PMID[21757344].
[Pubmed]. OI_0706-072011.
2. Synthesis of Aryl Aldimines and Their Activity against Fungi of Clinical Interest.da Silva, C.M., D.L. da Silva, C.V. Martins, M.A. de Resende, E.S. Dias, T.F. Magalhaes, L.P. Rodrigues, A.A. Sabino, R.B. Alves, and A. de Fatima. Chemical Biology & Drug Design, 2011. [Epub ahead of print]; PMID[21756287].
[Pubmed]. OI_0706-072011.
ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)
3. Aryl-2-[1H-benzotriazol-1-yl]acrylonitriles: A Novel Class of Potent Tubulin Inhibitors. Carta, A., I. Briguglio, S. Piras, G. Boatto, P. La Colla, R. Loddo, M. Tolomeo, S. Grimaudo, A. Di Cristina, R.M. Pipitone, E. Laurini, M.S. Paneni, P. Posocco, M. Fermeglia, and S. Pricl. European Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21741130].
[Pubmed]. OI_0706-072011.
4. Structure-Activity Relationships of Antitubercular Nitroimidazoles. 3. Exploration of the Linker and Lipophilic Tail of ((S)-2-nitro-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazin-6-yl)-(4-trifluoromethoxybe nzyl)amine (6-amino PA-824). Cherian, J., I. Choi, A. Nayyar, U. Manjunatha, T. Mukherjee, Y.S. Lee, H.I. Boshoff, R. Singh, Y.H. Ha, M. Goodwin, S.B. Lakshminarayana, P. Niyomrattanakit, J. Jiricek, S. Ravindran, T. Dick, T.H. Keller, V. Dartois, and C.E. Barry 3rd. Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21755942].
[Pubmed]. OI_0706-072011.
5. Total Synthesis of a Depsidomycin Analogue by Convergent Solid-phase Peptide Synthesis and Macrolactonization Strategy for Antitubercular Activity. Narayanaswamy, V.K., F. Albericio, Y.M. Coovadia, H.G. Kruger, G.E. Maguire, M. Pillay, and T. Govender. Journal of Peptide Science: an Official Publication of the European Peptide Society, 2011. [Epub ahead of print]; PMID[21766389].
[Pubmed]. OI_0706-072011.
6. A New Class of 2-(4-Cyanophenyl amino)-4-(6-bromo-4-quinolinyloxy)-6-piperazinyl (piperidinyl)-1,3,5-triazine Analogues with Antimicrobial/Antimycobacterial Activity. Patel, R.V., P. Kumari, D.P. Rajani, and K.H. Chikhalia. Journal of Enzyme Inhibition and Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21740100].
[Pubmed]. OI_0706-072011.
7. Synthesis of Some Pyrazolines and Pyrimidines Derived from Polymethoxy Chalcones as Anticancer and Antimicrobial Agents. Rostom, S.A., M.H. Badr, H.A. Abd El Razik, H.M. Ashour, and A.E. Abdel Wahab. Archiv Der Pharmazie, 2011. [Epub ahead of print]; PMID[21755528].
[Pubmed]. OI_0706-072011.
8. Synthesis and Minimum Inhibitory Concentrations of SK-03-92 against Staphylococcus aureus and Other Gram-positive Bacteria. Schwan, W.R., M.S. Kabir, M. Kallaus, S. Krueger, A. Monte, and J.M. Cook. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy, 2011. [Epub ahead of print]; PMID[21739106].
[Pubmed]. OI_0706-072011.
9. Synthesis and Evaluation of Chromenyl Barbiturates and Thiobarbiturates as Potential Antitubercular Agents. Vijaya Laxmi, S., Y. Thirupathi Reddy, B. Suresh Kuarm, P. Narsimha Reddy, P.A. Crooks, and B. Rajitha. Bioorganic & Medicinal Chemistry Letters, 2011. 21(14): p. 4329-4331; PMID[21684158].
[Pubmed]. OI_0706072011.
ANTIMALARIAL COMPOUNDS (Plasmodium spp.)
10. Antiplasmodial, Anti-inflammatory and Cytotoxic Activities of Various Plant Extracts from the Mascarene Archipelago. Jonville, M.C., H. Kodja, D. Strasberg, A. Pichette, E. Ollivier, M. Frederich, L. Angenot, and J. Legault. Journal of Ethnopharmacology, 2011. 136(3): p. 525-531; PMID[20600776].
[Pubmed]. OI_0706-072011.
11. In vitro sensitivity of Plasmodium falciparum Field Isolates to Extracts from Cameroonian Annonaceae Plants. Kemgne, E.A., W.F. Mbacham, F.F. Boyom, P.H. Zollo, E. Tsamo, and P.J. Rosenthal. Parasitology Research, 2011. [Epub ahead of print]; PMID[21739316].
[Pubmed]. OI_0706-072011.
12. Characterization of In vivo Metabolites of WR319691, a Novel Compound with Activity Against Plasmodium falciparum. Milner, E., J. Sousa, B. Pybus, V. Melendez, S. Gardner, K. Grauer, J. Moon, D. Carroll, J. Auschwitz, M. Gettayacamin, P. Lee, S. Leed, W. McCalmont, S. Norval, A. Tungtaeng, Q. Zeng, M. Kozar, K.D. Read, Q. Li, and G. Dow. European Journal of Drug Metabolism and Pharmacokinetics, 2011. [Epub ahead of print]; PMID[21751074].
[Pubmed]. OI_0706-072011.
13. Antimalarial Activity of Natural and Synthetic Prodiginines. Papireddy, K., M. Smilkstein, J.X. Kelly, Shweta, S.M. Salem, M. Alhamadsheh, S.W. Haynes, G.L. Challis, and K.A. Reynolds. Journal of Medicinal Chemistry, 2011. [Epub ahead of print]; PMID[21736388].
[Pubmed]. OI_0706-072011.
14. In vitro Activity of Antifungal Drugs against Plasmodium falciparum Field Isolates. Pongratz, P., F. Kurth, G.M. Ngoma, A. Basra, and M. Ramharter. Wien Klin Wochenschr, 2011. [Epub ahead of print]; PMID[21739204].
[Pubmed]. OI_0706-072011.
ANTILEISHMANIA COMPOUNDS
15. Design, Synthesis and Antileishmanial In vitro Activity of New Series of Chalcones-like Compounds: A Molecular Hybridization Approach. Barbosa, T.P., S.C. Sousa, F.M. Amorim, Y.K. Rodrigues, P.A. de Assis, J.P. Caldas, M.R. Oliveira, and M.L. Vasconcellos. Bioorganic & Medicinal Chemistry, 2011. 19(14): p. 4250-4256; PMID[21684751].
[Pubmed]. OI_0706-072011.
16. Anti-leishmanial Activity of Disubstituted Purines and Related Pyrazolo[4,3-d]pyrimidines. Jorda, R., N. Sacerdoti-Sierra, J. Voller, L. Havlicek, K. Kracalikova, M.W. Nowicki, A. Nasereddin, V. Krystof, M. Strnad, M.D. Walkinshaw, and C.L. Jaffe. Bioorganic & Medicinal Chemistry Letters, 2011. 21(14): p. 4233-4237; PMID[21683592].
[Pubmed]. OI_0706-072011.
Citations from the ISI Web of Knowledge Listings for O.I.
17. Honey Flavonoids, Natural Antifungal Agents Against Candida Albicans. Candiracci, M., B. Citterio, G. Diamantini, M. Blasa, A. Accorsi, and E. Piatti. International Journal of Food Properties, 2011. 14(4): p. 799-808; ISI[000291863100010].
[WOS]. OI_0706-072011.
18. Design, Synthesis and Molecular Docking Studies of Novel Triazole as Antifungal Agent. Chai, X.Y., J. Zhang, Y.B. Cao, Y. Zou, Q.Y. Wu, D.Z. Zhang, Y.Y. Jiang, and Q.Y. Sun. European Journal of Medicinal Chemistry, 2011. 46(7): p. 3167-3176; ISI[000291895200061].
[WOS]. OI_0706-072011.
19. Total Synthesis of Racemic and (R) and (S)-4-Methoxyalkanoic acids and Their Antifungal Activity. Das, B., D.B. Shinde, B.S. Kanth, A. Kamle, and C.G. Kumar. European Journal of Medicinal Chemistry, 2011. 46(7): p. 3124-3129; ISI[000291895200055].
[WOS]. OI_0706-072011.
20. Thiazole, Oxadiazole, and Carboxamide Derivatives of Artemisinin are Highly Selective and Potent Inhibitors of Toxoplasma gondii. Hencken, C.P., L. Jones-Brando, C. Bordon, R. Stohler, B.T. Mott, R. Yolken, G.H. Posner, and L.E. Woodard. Abstracts of Papers of the American Chemical Society, 2011. ISI[000291982806218].
[WOS]. OI_0706-072011.
21. Design, Synthesis and Characterization of Thiophene-arabinoside Conjugates as Inhibitors of Mycobacterium tuberculosis Antigen 85C. Ibrahim, D.A., K.R. Trabbic, S.S. Adams, A.K. Sanki, J. Boucau, D.H. Lajiness, D.R. Ronning, and S.J. Sucheck. Abstracts of Papers of the American Chemical Society, 2011.ISI[000291982802329].
[WOS]. OI_0706-072011.
22. Synthesis and Antitubercular Evaluation of Amidoalkyl dibenzofuranols and 1H-Benzo 2,3 benzofuro 4,5-e 1,3 oxazin-3(2H)-ones. Kantevari, S., T. Yempala, P. Yogeeswari, D. Sriram, and B. Sridhar. Bioorganic & Medicinal Chemistry Letters, 2011. 21(14): p. 4316-4319; ISI[000292186400043].
[WOS]. OI_0706-072011.
23. Mycobacterium tuberculosis and Cholinesterase Inhibitors from Voacanga globosa. Macabeo, A.P.G., W.S. Vidar, X.Y. Chen, M. Decker, J. Heilmann, B.J. Wan, S.G. Franzblau, E.V. Galvez, M.A.M. Aguinaldo, and G.A. Cordell. European Journal of Medicinal Chemistry, 2011. 46(7): p. 3118-3123; ISI[000291895200054].
[WOS]. OI_0706-072011.
24. Studies on the Antimicrobial Activity and Chemical Composition of the Essential Oils and Alcoholic Extracts of Gentiana asclepiadea L. Mihailovic, V., N. Vukovic, N. Niciforovic, S. Solujic, M. Mladenovic, P. Maskovic, and M.S. Stankovic. Journal of Medicinal Plants Research, 2011. 5(7): p. 1164-1174; ISI[000291888600017].
[WOS]. OI_0706-072011.
25. Bio-activities of Extracts from Some Axenically Farmed and Naturally Grown Bryophytes. Sabovljevic, A., M. Sokovic, J. Glamoclija, A. Ciric, M. Vujicic, B. Pejin, and M. Sabovljevic. Journal of Medicinal Plants Research, 2011. 5(4): p. 565-571; ISI[000291886800014].
[WOS]. OI_0706-072011.
26. Synthesis of 4-Hydroxycoumarin Heteroarylhybrids as Potential Antimicrobial Agents. Siddiqui, Z.N., T.N.M. Musthafa, A. Ahmad, and A.U. Khan. Archiv Der Pharmazie, 2011. 344(6): p. 394-401; ISI[000292003400006].
[WOS]. OI_0706-072011.
27. Estimation of Phytoconstituents from Cryptostegia grandiflora (Roxb.) R. Br. In vivo and In vitro. II. Antimicrobial Screening. Singh, B., R.A. Sharma, G.K. Vyas, and P. Sharma. Journal of Medicinal Plants Research, 2011. 5(9): p. 1598-1605; ISI[000291889500016].
[WOS]. OI_0706-072011.
28. Synthesis and Antimicrobial Activities of Hexahydroimidazo 1,5-a Pyridinium bromides with Varying Benzyl Substituents.Turkmen, H., N. Ceyhan, N.U.K. Yavasoglu, G. Ozdemir, and B. Cetinkaya. European Journal of Medicinal Chemistry, 2011. 46(7): p. 2895-2900; ISI[000291895200026].
[WOS]. OI_0706-072011.
29. Design, Synthesis and Antifungal Activities of Novel 1,2,4-Triazole Derivatives. Xu, J.M., Y.B. Cao, J. Zhang, S.C. Yu, Y. Zou, X.Y. Chai, Q.Y. Wu, D.Z. Zhang, Y.Y. Jiang, and Q.Y. Sun. European Journal of Medicinal Chemistry, 2011. 46(7): p. 3142-3148; ISI[000291895200058].
[WOS]. OI_0706-072011.